Measurements of gluconeogenesis and glycogenolysis: A methodological review

Diabetes

Volumn 64, Issue 12, 2015, Pages 3996-4010

  Chung, Stephanie T ^a   Chacko, Shaji K ^b   Sunehag, Agneta L ^b   Haymond, Morey W ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ALANINE; DEUTERIUM; DEUTERIUM OXIDE; GLUCOSE; GLUCOSE C 13; GLYCEROL; ISOTOPE; LACTIC ACID; STABLE ISOTOPE; TRACER; UNCLASSIFIED DRUG;

ARTICLE; BODY WATER; CARBON NUCLEAR MAGNETIC RESONANCE; GENE EXPRESSION; GLUCONEOGENESIS; GLYCOGENOLYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION STATE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBSTRATE CONCENTRATION; ANIMAL; BIOLOGICAL MODEL; ENZYMOLOGY; EVIDENCE BASED MEDICINE; KIDNEY; LIVER; MEDICAL RESEARCH; METABOLISM; TRENDS;

ANIMALS; BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; GLUCONEOGENESIS; GLYCOGENOLYSIS; HUMANS; KIDNEY; LIVER; MODELS, BIOLOGICAL;

EID: 84962170716     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0640     Document Type: Article

References (122)

1. Ekberg K, Landau BR, Wajngot A, et al. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes 1999;48:292-298
2. Mohammad MA, Sunehag AL, Chacko SK, Pontius AS, Maningat PD, Haymond MW. Mechanisms to conserve glucose in lactating women during a 42-h fast. Am J Physiol Endocrinol Metab 2009;297:E879-E888
3. Lin HV, Accili D. Hormonal regulation of hepatic glucose production in health and disease. Cell Metab 2011;14:9-19
4. Burgess SC, He T, Yan Z, et al. Cytosolic phosphoenolpyruvate carboxy-kinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab 2007;5:313-320
5. Samuel VT, Beddow SA, Iwasaki T, et al. Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with type 2 diabetes. Proc Natl Acad Sci U S A 2009;106:12121-12126
6. Ramnanan CJ, Edgerton DS, Rivera N, et al. Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo. Diabetes 2010;59:1302-1311
7. Cori CF, Cori GT. Glycogen formation in the liver from d- and l-lactic acid. J Biol Chem 1929;81:389-403
8. Cori GT, Cori CF. Glucose-6-phosphatase of the liver in glycogen storage disease. J Biol Chem 1952;199:661-667
9. Reichard GA Jr, Jacobs AG, Kimbel P, Hochella NJ, Weinhouse S. Blood glucose replacement rates in normal and diabetic humans. J Appl Physiol 1961; 16:789-795
10. Owen OE, Felig P, Morgan AP, Wahren J, Cahill GF Jr. Liver and kidney metabolism during prolonged starvation. J Clin Invest 1969;48:574-583
11. Atwell ME, Waterhouse C. Glucose production from fructose. Diabetes 1971;20:193-199
12. Tigas S, Sunehag A, Haymond MW. Metabolic adaptation to feeding and fasting during lactation in humans. J Clin Endocrinol Metab 2002;87:302-307
13. Haymond MW, Karl IE, Feigin RD, DeVivo D, Pagliara AS. Hypoglycemia and maple syrup urine disease: defective gluconeogenesis. Pediatr Res 1973;7:500-508
14. Haymond MW, Karl IE, Clarke WL, Pagliara AS, Santiago JV. Differences in circulating gluconeogenic substrates during short-term fasting in men, women, and children. Metabolism 1982;31:33-42
15. Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 2009;297:E578-E591
16. Cherrington AD, Williams PE, Shulman GI, Lacy WW. Differential time course of glucagon's effect on glycogenosis and gluconeogenesis in the conscious dog. Diabetes 1981;30:180-187
17. Edgerton DS, Cardin S, Emshwiller M, et al. Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism. Diabetes 2001;50:1872-1882
18. Bier DM. The use of stable isotopes in metabolic investigation. Baillieres Clin Endocrinol Metab 1987;1:817-836
19. Stingl H, Chandramouli V, Schumann WC, et al. Changes in hepatic glycogen cycling during a glucose load in healthy humans. Diabetologia 2006;49:360-368
20. Kacerovsky M, Jones J, Schmid AI, et al. Postprandial and fasting hepatic glucose fluxes in long-standing type 1 diabetes. Diabetes 2011;60:1752-1758
21. Bier DM, Leake RD, Haymond MW, et al. Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 1977;26:1016-1023
22. Allick G, van der Crabben SN, Ackermans MT, Endert E, Sauerwein HP. Measurement of gluconeogenesis by deuterated water: the effect of equilibration time and fasting period. Am J Physiol Endocrinol Metab 2006;290:E1212-E1217
23. Toffolo G, Cobelli C. The hot IVGTT two-compartment minimal model: an improved version. Am J Physiol Endocrinol Metab 2003;284:E317-E321
24. Toffolo G, Basu R, Dalla Man C, Rizza R, Cobelli C. Assessment of postprandial glucose metabolism: conventional dual- vs. triple-tracer method. Am J Physiol Endocrinol Metab 2006;291:E800-E806
25. Chiasson JL, Liljenquist JE, Lacy WW, Jennings AS, Cherrington AD. Gluconeogenesis: methodological approaches in vivo. Fed Proc 1977;36:229-235
26. Kaplan W, Sunehag AL, Dao H, Haymond MW. Short-term effects of recombinant human growth hormone and feeding on gluconeogenesis in humans. Metabolism 2008;57:725-732
27. Mohammad MA, Maningat P, Sunehag AL, Haymond MW. Precursors of hexoneogenesis within the human mammary gland. Am J Physiol Endocrinol Metab 2015;308:E680-E687
28. Meyer C, Stumvoll M, Dostou J, Welle S, Haymond M, Gerich J. Renal substrate exchange and gluconeogenesis in normal postabsorptive humans. Am J Physiol Endocrinol Metab 2002;282:E428-E434
29. Goodman AD, Fuisz RE, Cahill GF Jr. Renal gluconeogenesis in acidosis, alkalosis, and potassium deficiency: its possible role in regulation of renal ammonia production. J Clin Invest 1966;45:612-619
30. Kamm DE, Fuisz RE, Goodman AD, Cahill GF Jr. Acid-base alterations and renal gluconeogenesis: effect of pH, bicarbonate concentration, and PCO2. J Clin Invest 1967;46:1172-1177
31. Chacko SK, Ordonez J, Sauer PJJ, Sunehag AL. Gluconeogenesis is not regulated by either glucose or insulin in extremely low birth weight infants receiving total parenteral nutrition. J Pediatr 2011;158:891-896
32. Chacko SK, Sunehag AL. Gluconeogenesis continues in premature infants receiving total parenteral nutrition. Arch Dis Child Fetal Neonatal Ed 2010;95: F413-F418
33. Chacko SK, Sunehag AL, Sharma S, Sauer PJJ, Haymond MW. Measurement of gluconeogenesis using glucose fragments and mass spectrometry after ingestion of deuterium oxide. J Appl Physiol (1985) 2008;104:944-951
34. Haymond MW, Sunehag AL. The reciprocal pool model for the measurement of gluconeogenesis by use of [U-(13)C]glucose. Am J Physiol Endocrinol Metab 2000;278:E140-E145
35. Sunehag AL, Haymond MW, Schanler RJ, Reeds PJ, Bier DM. Gluconeogenesis in very low birth weight infants receiving total parenteral nutrition. Diabetes 1999;48:791-800
36. Sunehag AL, Treuth MS, Toffolo G, et al. Glucose production, gluconeogenesis, and insulin sensitivity in children and adolescents: an evaluation of their reproducibility. Pediatr Res 2001;50:115-123
37. Hetenyi G Jr, Lussier B, Ferrarotto C, Radziuk J. Calculation of the rate of gluconeogenesis from the incorporation of 14C atoms from labelled bicarbonate or acetate. Can J Physiol Pharmacol 1982;60:1603-1609
38. Katz J. Determination of gluconeogenesis in vivo with 14C-labeled substrates. Am J Physiol 1985;248:R391-R399
39. Consoli A, Nurjhan N, Capani F, Pangburn T, Lapenna D, Gerich J. Limitations in the use of [2-14C]acetate for measuring gluconeogenesis in vivo. Diabetes 1993;42:732-737
40. Consoli A, Nurjhan N, Capani F, Gerich J. Predominant role of gluconeo-genesis in increased hepatic glucose production in NIDDM. Diabetes 1989;38: 550-557
41. Landau BR, Wahren J, Previs SF, Ekberg K, Chandramouli V, Brunengraber H. Glycerol production and utilization in humans: sites and quantitation. Am J Physiol 1996;271:E1110-E1117
42. Consoli A, Nurjhan N, Reilly JJ Jr, Bier DM, Gerich JE. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. J Clin Invest 1990;86:2038-2045
43. Jenssen T, Nurjhan N, Consoli A, Gerich JE. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest 1990;86:489-497
44. Landau BR, Chandramouli V, Schumann WC, et al. Estimates of Krebs cycle activity and contributions of gluconeogenesis to hepatic glucose production in fasting healthy subjects and IDDM patients. Diabetologia 1995;38: 831-838
45. Perriello G, Pampanelli S, Del Sindaco P, et al. Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes 1997;46:1010-1016
46. Garber AJ, Cryer PE, Santiago JV, Haymond MW, Pagliara AS, Kipnis DM. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest 1976;58:7-15
47. Hellerstein MK, Neese RA, Linfoot P, Christiansen M, Turner S, Letscher A. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study. J Clin Invest 1997;100:1305-1319
48. Neese RA, Schwarz JM, Faix D, et al. Gluconeogenesis and intrahepatic triose phosphate flux in response to fasting or substrate loads. Application of the mass isotopomer distribution analysis technique with testing of assumptions and potential problems. J Biol Chem 1995;270:14452-14466
49. 13C]glucose study. Am J Physiol 1996;270:E709-E717
50. Katz J, Tayek JA. Recycling of glucose and determination of the Cori cycle and gluconeogenesis. Am J Physiol 1999;277:E401-E407
51. Hellerstein MK, Neese RA. Mass isotopomer distribution analysis: a technique for measuring biosynthesis and turnover of polymers. Am J Physiol 1992;263:E988-E1001
52. Hellerstein MK, Neese RA. Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations. Am J Physiol 1999; 276:E1146-E1170
53. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC. Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 1996;98:378-385
54. Previs SF, Fernandez CA, Yang D, Soloviev MV, David F, Brunengraber H. Limitations of the mass isotopomer distribution analysis of glucose to study gluconeogenesis. Substrate cycling between glycerol and triose phosphates in liver. J Biol Chem 1995;270:19806-19815
55. Landau BR, Fernandez CA, Previs SF, et al. A limitation in the use of mass isotopomer distributions to measure gluconeogenesis in fasting humans. Am J Physiol 1995;269:E18-E26
56. Jungermann K, Kietzmann T. Zonation of parenchymal and nonparenchymal metabolism in liver. Annu Rev Nutr 1996;16:179-203
57. Kalderon B, Gopher A, Lapidot A. Metabolic pathways leading to liver glycogen repletion in vivo, studied by GC-MS and NMR. FEBS Lett 1986;204:29-32
58. Katz J, Tayek JA Gluconeogenesis and the Cori cycle in 12-, 20-, and 40-h-fasted humans. Am J Physiol 1998;275:E537-E542
59. Nilsson LH. Liver glycogen content in man in the postabsorptive state. Scand J Clin Lab Invest 1973;32:317-323
60. Nilsson LH, Fürst P, Hultman E. Carbohydrate metabolism of the liver in normal man under varying dietary conditions. Scand J Clin Lab Invest 1973;32: 331-337
61. Nilsson LH, Hultman E. Liver glycogen in man-the effect of total starvation or a carbohydrate-poor diet followed by carbohydrate refeeding. Scand J Clin Lab Invest 1973;32:325-330
62. Sillerud LO, Shulman RG. Structure and metabolism of mammalian liver glycogen monitored by carbon-13 nuclear magnetic resonance. Biochemistry 1983;22:1087-1094
63. 13C NMR measurements of liver glycogen in vivo. Magn Reson Med 1994;31:583-588
64. 13C NMR. Science 1991;254:573-576
65. Magnusson I, Rothman DL, Jucker B, Cline GW, Shulman RG, Shulman GI. Liver glycogen turnover in fed and fasted humans. Am J Physiol 1994;266:E796-E803
66. Petersen KF, Laurent D, Rothman DL, Cline GW, Shulman GI. Mechanism by which glucose and insulin inhibit net hepatic glycogenosis in humans. J Clin Invest 1998;101:1203-1209
67. 13C nuclear magnetic resonance study. J Clin Invest 1992;90:1323-1327
68. Petersen KF, Price T, Cline GW, Rothman DL, Shulman GI. Contribution of net hepatic glycogenosis to glucose production during the early postprandial period. Am J Physiol 1996;270:E186-E191
69. Rose IA. Mechanism of the aldose-ketose isomerase reactions. Adv En-zymol Relat Areas Mol Biol 1975;43:491-517
70. Wajngot A, Chandramouli V, Schumann WC, Kumaran K, Efendic S, Landau BR. Testing of the assumptions made in estimating the extent of futile cycling. Am J Physiol 1989;256:E668-E675
71. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC. Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state. J Clin Invest 1995;95:172-178
72. Rognstad R. Estimation of gluconeogenesis and glycogenosis in vivo using tritiated water. Biochem J 1991;279:911
73. Kuwajima M, Golden S, Katz J, Unger RH, Foster DW, McGarry JD. Active hepatic glycogen synthesis from gluconeogenic precursors despite high tissue levels of fructose 2,6-bisphosphate. J Biol Chem 1986;261:2632-2637
74. Kunert O, Stingl H, Rosian E, et al. Measurement of fractional whole-body gluconeogenesis in humans from blood samples using 2H nuclear magnetic resonance spectroscopy. Diabetes 2003;52:2475-2482
75. Sunehag AL, Toffolo G, Treuth MS, et al. Effects of dietary macronutrient content on glucose metabolism in children. J Clin Endocrinol Metab 2002;87: 5168-5178
76. Jones JG, Solomon MA, Cole SM, Sherry AD, Malloy CR. An integrated (2)H and (13)C NMR study of gluconeogenesis and TCA cycle flux in humans. Am J Physiol Endocrinol Metab 2001;281:E848-E856
77. Jones JG, Perdigoto R, Rodrigues TB, Geraldes CFGC. Quantitation of absolute 2H enrichment of plasma glucose by 2H NMR analysis of its mono-acetone derivative. Magn Reson Med 2002;48:535-539
78. Leadlay PF, Albery WJ, Knowles JR. Energetics of triosephosphate isomerase: deuterium isotope effects in the enzyme-catalyzed reaction. Biochemistry 1976;15:5617-5620
79. Chandramouli V, Ekberg K, Schumann WC, Wahren J, Landau BR. Origins of the hydrogen bound to carbon 1 of glucose in fasting: significance in gluco-neogenesis quantitation. Am J Physiol 1999;277:E717-E723
80. Chandramouli V, Ekberg K, Schumann WC, Kalhan SC, Wahren J, Landau BR. Quantifying gluconeogenesis during fasting. Am J Physiol 1997;273:E1209-E1215
81. Basu R, Chandramouli V, Dicke B, Landau BR, Rizza RA. Plasma C5 glucose-to-2H2O ratio does not provide an accurate assessment of gluconeogenesis during hyperinsulinemic-euglycemic clamps in either nondiabetic or diabetic humans. Diabetes 2008;57:1800-1804
82. Sunehag AL, Toffolo G, Campioni M, Bier DM, Haymond MW. Effects of dietary macronutrient intake on insulin sensitivity and secretion and glucose and lipid metabolism in healthy, obese adolescents. J Clin Endocrinol Metab 2005;90: 4496-4502
83. Krebs M, Brehm A, Krssak M, et al. Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia 2003;46:917-925
84. Basu R, Chandramouli V, Dicke B, Landau B, Rizza R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenosis as well as gluconeogenesis. Diabetes 2005;54:1942-1948
85. Bock G, Chittilapilly E, Basu R, et al. Contribution of hepatic and extra-hepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis. Diabetes 2007;56:1703-1711
86. Basu R, Barosa C, Jones J, et al. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia. J Clin Endocrinol Metab 2013;98:E409-E417
87. Gastaldelli A, Miyazaki Y, Pettiti M, et al. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenosis. J Clin Endocrinol Metab 2004;89:3914-3921
88. Bock G, Schumann WC, Basu R, et al. Evidence that processes other than gluconeogenesis may influence the ratio of deuterium on the fifth and third carbons of glucose: implications for the use of 2H2O to measure gluconeogenesis in humans. Diabetes 2008;57:50-55
89. Rognstad R, Clark G, Katz J. Glucose synthesis in tritiated water. Eur J Biochem 1974;47:383-388
90. Guo ZK, Lee WN, Katz J, Bergner AE. Quantitation of positional isomers of deuterium-labeled glucose by gas chromatography/mass spectrometry. Anal Biochem 1992;204:273-282
91. Szafranek J, Pfaffenberger CD, Horning EC. The mass spectra of some per-O-acetylaldononitriles. Carbohydr Res 1974;38:97-105
92. Shalwitz RA, Beth TJ, MacLeod AM, Tucker SJ, Rolison GG. Use of 2H2O to study labeling in plasma glucose and hepatic glycogen during a hyperglycemic clamp. Am J Physiol 1994;266:E433-E437
93. Jin ES, Jones JG, Merritt M, Burgess SC, Malloy CR, Sherry AD. Glucose production, gluconeogenesis, and hepatic tricarboxylic acid cycle fluxes measured by nuclear magnetic resonance analysis of a single glucose derivative. Anal Biochem 2004;327:149-155
94. Chacko SK, Haymond MW, Sun Y, et al. Effect of ghrelin on glucose regulation in mice. Am J Physiol Endocrinol Metab 2012;302:E1055-E1062
95. Antoniewicz MR, Kelleher JK, Stephanopoulos G. Measuring deuterium enrichment of glucose hydrogen atoms by gas chromatography/mass spectrometry. Anal Chem 2011;83:3211-3216
96. Burgess SC, Nuss M, Chandramouli V, et al. Analysis of gluconeogenic pathways in vivo by distribution of 2H in plasma glucose: comparison of nuclear magnetic resonance and mass spectrometry. Anal Biochem 2003;318:321-324
97. Schleucher J, Vanderveer PJ, Sharkey TD. Export of carbon from chloro-plasts at night. Plant Physiol 1998;118:1439-1445
98. Burgess SC, Chandramouli V, Browning JD, Schumann WC, Previs SF. Complicating factors in the application of the "average method" for determining the contribution of gluconeogenesis. J Appl Physiol (1985) 2008;104:1852-1853; author reply 1854-1855
99. Chacko SK, Sunehag AL, Sharma S, Sauer PJJ, Haymond MW. Reply to Burgess, Chandramouli, Browning, Schumann, and Previs. J Appl Physiol 2008; 104:1854-1855
100. Bederman IR, Chandramouli V, Sandlers Y, Henderson L, Cabrera ME. Time course of hepatic gluconeogenesis during hindlimb suspension unloading. Exp Physiol 2013;98:278-289
101. 2O in humans. Eur J Appl Physiol 2012;112:2213-2222
102. Basu R, Barosa C, Basu A, et al. Transaldolase exchange and its effects on measurements of gluconeogenesis in humans. Am J Physiol Endocrinol Metab 2011;300:E296-E303
103. Rajpal A, Dube S, Carvalho F, et al. Effects of transaldolase exchange on estimates of gluconeogenesis in type 2 diabetes. Am J Physiol Endocrinol Metab 2013;305:E465-E474
104. Efendic S, Wajngot A, Vranic M. Increased activity of the glucose cycle in the liver: early characteristic of type 2 diabetes. Proc Natl Acad Sci U S A 1985; 82:2965-2969
105. Sunehag AL. Parenteral glycerol enhances gluconeogenesis in very premature infants. Pediatr Res 2003;53:635-641
106. Gastaldelli A, Cusi K, Pettiti M, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 2007;133:496-506
107. Vella A, Shah P, Basu R, et al. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia 2001;44:729-737
108. Chung ST, Hsia DS, Chacko SK, Rodriguez LM, Haymond MW. Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes. Diabetologia 2015;58:596-603
109. Gastaldelli A, Toschi E, Pettiti M, et al. Effect of physiological hyper-insulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes 2001;50:1807-1812
110. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981;240:E630-E639
111. 3H]glucose. Am J Physiol 1990;258:E228-E233
112. Adkins A, Basu R, Persson M, et al. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenosis in nondiabetic humans. Diabetes 2003;52:2213-2220
113. Gastaldelli A, Baldi S, Pettiti M, et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 2000;49:1367-1373
114. Boden G, Chen X, Capulong E, Mozzoli M. Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes 2001;50:810-816
115. Wajngot A, Chandramouli V, Schumann WC, et al. Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus. Metabolism 2001;50:47-52
116. Bock G, Dalla Man C, Campioni M, et al. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 2006;55:3536-3549
117. Hundal RS, Krssak M, Dufour S, et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000;49:2063-2069
118. Basu R, Shah P, Basu A, et al. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes. Diabetes 2008;57:24-31
119. Degn KB, Juhl CB, Sturis J, et al. One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes. Diabetes 2004; 53:1187-1194
120. Puhakainen I, Koivisto VA, Yki-Järvinen H. Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1992;75:789-794
121. Nurjhan N, Campbell PJ, Kennedy FP, Miles JM, Gerich JE. Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes 1986;35:1326-1331
122. 13C NMR isotopomer analysis of human urine. Anal Biochem 2003;312:228-234